This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of astragaloside supplementation on joint discomfort in healthy adults. The primary goal is to determine if daily intake of astragaloside can improve knee joint function and reduce discomfort over a 12-week period. Participants will be randomly assigned to receive either an astragaloside capsule or a placebo capsule once daily. Aim to see if those taking astragaloside experience better mobility and fewer joint-related symptoms compared to those in the placebo group.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline in knee joint stability via SLSD test at 12 weeks.
Timeframe: From baseline to Week 12
Change from baseline in knee Range of Motion (ROM) at 12 weeks.
Timeframe: From baseline to Week 12
Change from baseline in KOOS score at 12 weeks.
Timeframe: From baseline to Week 12